fbpx
  • Home
  • Study Details
By physician referral or invitation only

Adapt Out COVID

The purpose of this study is to evaluate the ability of various drugs to improve health outcomes for people with COVID-19. We also want to see if these drugs are safe, and if these drugs can stop the disease process and prevent hospitalization. This study is designed to quickly identify safe and effective drugs that can treat COVID-19. This study will be done at an international site and overseen by research team in Malawi; Research for Me will not be applicable.

Age & Gender

  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

International (Malawi)

Additional Study Information

Principal Investigator

Mina Hosseinipour
Medicine-Infectious Diseases

Study Type

Clinical or Medical
Interventional

Study Topics

COVID-19

IRB Number

21-0860

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.